Abstract
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but life-threatening pulmonary vascular disease caused by the presence of a prolonged thrombus in the pulmonary artery. CTEPH is a distinct disease entity classified as group 4 pulmonary hypertension according to the World Symposium on Pulmonary Hypertension. It is the only potentially curable cause of pulmonary hypertension. However, timely diagnosis and treatment are often hampered by nonspecific symptoms and signs and a lack of physician awareness regarding the condition. Thus, it is important to be familiar with the clinical features of CTEPH and the associated diagnostic processes. Herein, we cover the diagnostic approach for CTEPH using multimodal imaging tools in a clinical setting.
Funder
the Research Foundation of Internal Medicine, The Catholic University of Korea
Reference42 articles.
1. Haemodynamic definitions and updated clinical classification of pulmonary hypertension;Eur. Respir. J.,2019
2. Galie, N., Humbert, M., Vachiery, J.L., Gibbs, S., Lang, I., and Torbicki, A. (2022). 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Respir. J., 2200879, ahead of print.
3. Chronic complications of venous thromboembolism;J. Thromb. Haemost.,2017
4. Chronic Thromboembolic Pulmonary Hypertension: JACC Focus Seminar;J. Am. Coll. Cardiol.,2020
5. Thrombotic risk factors in pulmonary hypertension;Eur. Respir. J.,2000
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献